Mahamaya Lifesciences IPO

About the company

Incorporated in 2002, Mahamaya Lifesciences is engaged in the manufacturing of pesticide and bulk formulations catering to Indian agrochemical firms as well as multinational corporations (MNCs). The company operates a manufacturing facility located at Dahej, Gujarat. As of June 30, 2025, it offers a diverse product range including 136 insecticide products, 71 fungicide products, 58 herbicide products, 9 bio-stimulants, 3 biopesticides and 1 Biofertilizer. In FY25 domestic sales accounted for 95.30% of revenues at ₹251.73 crore and exports 4.70% at ₹12.42 crore. Capacity utilisation for solids stood at 113.37%, while that for liquids was 63.77% as of June, 2025. Its dealer network consists of 310+ dealers, spread across 8 states in India, and internationally, the company exports to countries such as Egypt, Turkey and UAE.

Financial performance (₹ Cr)

Subscription breakup (final, times)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   11 Nov 2025

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   13 Nov 2025

   Last day to place your bid

3. Basis of Allotment

   Completed
   14 Nov 2025

   Share allotment finalised

4. Refund Initiation

   Completed
   17 Nov 2025

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   17 Nov 2025

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   18 Nov 2025

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.